Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome

控制干燥综合征的自身免疫炎症并促进唾液腺再生

基本信息

批准号：
10528045
负责人：
Qing Yu
金额：
$ 24.88万
依托单位：
ADA FORSYTH INSTITUTE, INC.
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10528045
关键词：
Advanced Development Affect American Anabolism Anti-Inflammatory Agents Apoptosis Attenuated Autoimmune Autoimmune Diseases B-Lymphocytes Bioinformatics Biological Assay Biological Response Modifier Therapy Biological Response Modifiers C57BL/6 Mouse CD59 Antigen Cell Culture Techniques Cells Chronic Clinical Development Disease Flow Cytometry Functional disorder Health Hematoxylin and Eosin Staining Method High-Throughput RNA Sequencing Homeostasis Immune Immunofluorescence Immunologic Immunohistochemistry In Vitro Infiltration Inflammation Inflammatory Injury Innate Immune Response Knowledge Lacrimal gland structure Leukocytes Lipoxins Mediating Mediator of activation protein Methodology Methods Mus Natural regeneration Omega-3 Fatty Acids Oral Organ Organoids Pathway interactions Patients Polyunsaturated Fatty Acids Population Process Production Property Resolution Salivary Salivary Glands Signal Transduction Sjogren&apos s Syndrome Stains Stem cell transplant Structure System T-Lymphocyte Time Tissue Stains Tissues Transplantation Woman Xerostomia arachidonate attenuation autoimmune inflammation base chemokine cytokine draining lymph node eye dryness functional restoration healing immunoregulation in vivo inhibitor innovation insight lipid mediator lipoxin A4 matrigel mouse model novel receptor regenerative regenerative therapy restoration stem cell therapy stem cells stemness success tissue regeneration transcriptomics

项目摘要

PROJECT SUMMARY Sjӧgren’s syndrome is an autoimmune disease that causes chronic inflammation and damage/dysfunction of salivary and lacrimal glands, with hyposalivation as one of the main clinical manifestations. The disease greatly compromises the oral and systemic health of 4 million Americans, mostly women, with no cure or effective biological therapy. Stem cell therapies hold great promise for Sjӧgren’s disease, but the chronic autoimmune inflammation greatly impedes the likelihood of success. There is a critical need for new strategies and methods for attenuation of autoimmune inflammation achieve effective and sustained regeneration of the damaged and dysfunctional salivary glands. The objective of this exploratory project to elucidate the impact of specialized pro- resolving mediators (SPMs) on the expansion, renewal and immune-regulatory activity of salivary gland stem cells both in vitro and in vivo. SPMs are pro-resolving lipid mediators that mediate active resolution of inflammation and have demonstrated abilities to enhance the immunomodulatory, pro-healing and regenerative properties of stem cells. Moreover, SPMs can also be produced by stem cells. Our preliminary studies provided compelling evidence that SPMs positively impact both the stem cell activity and the immune-regulatory property of mouse salivary gland stem cells. Our innovative central hypothesis is that SPMs can promote sustainable structural and functional restoration of damaged salivary glands in Sjӧgren’s disease setting by acting on both salivary gland stem cells and immune/inflammatory cells to simultaneously mitigate autoimmune inflammation and enhance tissue regeneration. In Aim 1, we will examine whether lipoxin A4 and maresin-1 can boost the renewal, expansion, salivary organoid formation, SPM production and immune-regulatory activity of salivary gland stem cells from normal C57BL/6 mice in Matrigel-based expansion and differentiation culture systems. In Aim 2, we will determine if these SPMs can promote the structural and functional restoration of damaged salivary glands in Sjӧgren’s disease condition in vivo. Specifically, we will assess whether lipoxin A4 and maresin-1 administered to Sjӧgren’s disease-afflicted mice transplanted with salivary gland stem cells can simultaneously attenuate inflammation and enhance tissue regeneration, thereby achieving sustainable structural and functional restoration of salivary glands. Major methodologies employed in this project include Matrigel culture, intra- salivary gland cell transfer, high-throughput RNA-sequencing and bioinformatics, flow cytometry, real-time qPCR, immunohistochemistry and Luminex assay. Completion of this innovative exploratory project will elucidate the actions of SPMs in salivary gland stem cell-mediated tissue regeneration in the Sjögren’s disease condition. It will advance the development of stem cell therapies that concomitantly attenuate autoimmune inflammation and enhance tissue regeneration to achieve sustainable and effective restoration of salivary glands for Sjögren’s syndrome patients as well as patients with other salivary gland injury/ inflammatory conditions.

项目摘要 Sjnamegren综合征是一种自身免疫性疾病，会引起慢性炎症和损害/功能障碍唾液和泪腺，并成为主要临床表现之一。疾病极大地损害了400万美国人，主要是妇女的口腔和系统健康，没有治愈或有效生物疗法。干细胞疗法对Sjnamegren病具有巨大的希望，但慢性自身免疫炎症极大地阻碍了成功的可能性。迫切需要新的策略和方法为了衰减自身免疫性炎症，可有效且持续的损坏和持续再生功能失调的唾液腺。这个探索性项目的目的是阐明专业促进的影响解决唾液腺茎的扩张，更新和免疫调节活性的分辨介体（SPM）细胞在体外和体内。 SPM是支持分辨的脂质介质，可介导炎症，并表现出增强免疫调节，亲链和再生的能力干细胞的特性。此外，SPM也可以由干细胞产生。我们提供的初步研究 SPM对干细胞活性和免疫调节性质的积极影响的令人信服的证据小鼠唾液腺干细胞。我们创新的中心假设是，SPM可以促进可持续性 Sjnamegren病的设置唾液腺干细胞和免疫/炎症细胞同时减轻自身免疫性炎症并增强组织再生。在AIM 1中，我们将检查Lipoxin A4和Maresin-1是否可以提高更新，膨胀，唾液器官形成，SPM产生和唾液的免疫调节活性在基于矩阵的膨胀和分化培养系统中，来自正常C57BL/6小鼠的腺干细胞。在 AIM 2，我们将确定这些SPM是否可以促进受损唾液的结构和功能恢复 Sjnamegren疾病状况的腺体体内。具体而言，我们将评估脂氧蛋白A4和Maresin-1是否用唾液腺干细胞移植到Sjnamegren疾病伴有的小鼠很容易减轻炎症并增强组织再生，从而实现可持续的结构和功能恢复唾液腺。该项目中使用的主要方法包括矩阵培养，内部唾液腺细胞转移，高通量RNA测序和生物信息学，流式细胞术，实时qPCR，免疫组织化学和Luminex分析。该创新探索项目的完成将阐明 SPM在唾液腺干细胞介导的组织再生中的作用在Sjögren病疾病中。将促进同时减弱自身免疫注射和的干细胞疗法的发展增强组织再生，以实现Sjögren的唾液腺的可持续和有效恢复综合征患者以及患有其他唾液腺损伤/炎症状况的患者。